Longitudinal Examination of Metabolic and Behavioral Correlates of Protein Sources
Longitudinal Examination of Metabolic and Behavioral Correlates of Various Protein Food Sources
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Ashlea Braun, PhD
- Phone Number: 567-240-1582
- Email: ashlea.braun@okstate.edu
Study Locations
-
-
Oklahoma
-
Stillwater, Oklahoma, United States, 74078
- Oklahoma State University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-55 years of age
- Willingness to consume any of the three protein sources
- Willingness to stop consumption of any pre- or pro-biotic supplements
- Willingness to follow a meal plan for four weeks
Exclusion Criteria:
- Medical condition which precludes consumption of specific foods or whole food groups
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Beef
Individuals will be asked to consume beef as their only source of protein and follow an individualized meal plan for 4 weeks.
Thereafter, they will be instructed to continue beef consumption with any other foods desired for 4 weeks.
|
Fresh, locally-sourced, grass-fed, grass-finished ground beef sufficient to meet protein needs based on body weight for 8 weeks
|
|
Experimental: Meat analogue
Individuals will be asked to consume a commercial meat analogue product as their only source of protein and follow an individualized meal plan for 4 weeks.
Thereafter, they will be instructed to continue the meat analogue consumption with any other foods desired for 4 weeks.
|
Commercially-available and purchased meat analogue sufficient to meet protein needs based on body weight for 8 weeks
|
|
Experimental: Beans/legumes
Individuals will be asked to consume beans/legumes as their only source of protein and follow an individualized meal plan for 4 weeks.
Thereafter, they will be instructed to continue the bean/legume consumption with any other foods desired for 4 weeks.
|
Canned beans/legumes sufficient to meet protein needs based on body weight for 8 weeks
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body weight
Time Frame: Baseline (week 0), T1 (week 4), T2 (week 8)
|
In kilograms
|
Baseline (week 0), T1 (week 4), T2 (week 8)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Yale Food Addiction Scale
Time Frame: Baseline (week 0), T1 (week 4), T2 (week 8)
|
Continuous score = 0-7 (higher = more symptoms of food addiction)
|
Baseline (week 0), T1 (week 4), T2 (week 8)
|
|
Skin carotenoids
Time Frame: Baseline (week 0), T1 (week 4), T2 (week 8)
|
Baseline (week 0), T1 (week 4), T2 (week 8)
|
|
|
Dietary patterns (3-day diet records)
Time Frame: Baseline (week 0), T1 (week 4), T2 (week 8)
|
Baseline (week 0), T1 (week 4), T2 (week 8)
|
|
|
Behavioral Activation Scale Reward Responsiveness
Time Frame: Baseline (week 0), T1 (week 4), T2 (week 8)
|
Score ranges 5-20, higher scores indicate greater reward responsiveness
|
Baseline (week 0), T1 (week 4), T2 (week 8)
|
|
Sensitivity to Punishment and Reward Questionnaire (Reward Questions)
Time Frame: Baseline (week 0), T1 (week 4), T2 (week 8)
|
Score ranges 0-24, higher indicates greater sensitivity to reward
|
Baseline (week 0), T1 (week 4), T2 (week 8)
|
|
Fasting lipid panels (i.e., total cholesterol, HDL, LDL, VLDL, triglycerides)
Time Frame: Baseline (week 0), T1 (week 4), T2 (week 8)
|
Total cholesterol (mg/dL), HDL (mg/dL), LDL (mg/dL), triglycerides (mg/dL)
|
Baseline (week 0), T1 (week 4), T2 (week 8)
|
|
Fasting blood glucose
Time Frame: Baseline (week 0), T1 (week 4), T2 (week 8)
|
In mg/dL
|
Baseline (week 0), T1 (week 4), T2 (week 8)
|
|
Blood pressure
Time Frame: Baseline (week 0), T1 (week 4), T2 (week 8)
|
Systolic and diastolic (mmHg)
|
Baseline (week 0), T1 (week 4), T2 (week 8)
|
|
Ad-Libitum Ultra-Processed Food Consumption
Time Frame: Baseline (week 0), T1 (week 4), T2 (week 8)
|
Reported in weight of food consumed, greater than or equal to 0 grams
|
Baseline (week 0), T1 (week 4), T2 (week 8)
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- IRB-22-297-STW
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.